Skip to content
10-Q

Quarterly Report

VANGUARD HEALTH SYSTEMS INC

0001045829-12-000109

← back to feed
Filed
Nov 1, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · Oct 30, 2012 77.38M sh
Shares Diluted Q1 2013 · Sep 30, 2012 78.81M sh
Shares Diluted restated Q1 2013 · Sep 30, 2011 74.85M sh
Capex Q1 2013 · Sep 30, 2012 $82.7M
Capex Q1 2013 · Sep 30, 2011 $63.4M
Operating Cash Flow Q1 2013 · Sep 30, 2012 −$56.4M
Operating Cash Flow Q1 2013 · Sep 30, 2011 −$87.8M
Cash And Equivalents Q1 2013 · Sep 30, 2012 $330.2M
Cash And Equivalents Q1 2013 · Jun 30, 2012 $455.5M
Cash And Equivalents Q1 2013 · Sep 30, 2011 $154.7M
Cash And Equivalents Q1 2013 · Jun 30, 2011 $936.6M
Stockholders Equity Q1 2013 · Sep 30, 2012 $310.8M
Stockholders Equity Q1 2013 · Jun 30, 2012 $295.1M
Current Liabilities Q1 2013 · Sep 30, 2012 $826.6M
Current Liabilities Q1 2013 · Jun 30, 2012 $988.7M
Current Assets Q1 2013 · Sep 30, 2012 $1.41B
Current Assets Q1 2013 · Jun 30, 2012 $1.58B
Total Assets Q1 2013 · Sep 30, 2012 $4.59B
Total Assets Q1 2013 · Jun 30, 2012 $4.79B
Eps Diluted Q1 2013 · Sep 30, 2012 $0.17
Eps Diluted restated Q1 2013 · Sep 30, 2011 −$0.29
Eps Basic Q1 2013 · Sep 30, 2012 $0.18
Eps Basic restated Q1 2013 · Sep 30, 2011 −$0.29
Net Income Q1 2013 · Sep 30, 2012 $13.9M
Net Income restated Q1 2013 · Sep 30, 2011 −$21.7M